Battery / EV Metals Price BMI Lithium Carbonate, EXW China, >=99.2% Li2CO3 10,400 BMI Lithium Hydroxide, EXW China, >=56.5% LiOH 9,350 BMI Cobalt Sulphate, EXW China, >20.5% Co 3,528 BMI Nickel ...

U.S. stocks were edging higher in a quiet trading session on Tuesday, with the three major indexes on pace to close out the final trading day before the Christmas holiday on a high note. The Dow Jones ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Trade groups representing the largest U.S. banks on Tuesday filed suit in federal court to force more transparency in the U.S ...

Walmart's stock was climbing 1.3% in recent trading, which puts it on track to snap a four-day losing streak in which it shed 5.3%. J.P. Morgan analysts said in a note to clients that they were "more ...

The iShares 20+ Year Treasury Bond ETF was trading at $87.13, down 37 cents, or 0.4%, according to Dow Jones Market Data. That leaves it on track for its lowest close since November 2023. The ETF was ...

MultiPlan surged 59% after refinancing and extending the maturities of its entire debt capital structure. Shares were trading around $10 mid-morning Tuesday. The stock is down 85% on the year. The ...

As some financial advisers become more technology-driven and as low-cost robo-advisers gain more traction, some financial ...

Todd Garland, president of Bruker spatial biology division, said the company expects to promptly seek a stay of any injunction that is finally ordered in the case involving NanoString's GeoMx products ...

Slate Office Real Estate Investment Trust said Tuesday that it will internalize its management and change its name to Ravelin Properties REIT. The REIT said it has taken steps to accelerate the ...

American Airlines' stock was falling 2.6% in recent premarket trading, but pared an earlier loss of as much as 4.4% after the air carrier said all of its flights were being affected by a "technical ...

Achilles Therapeutics has sold certain technology assets to drug giant AstraZeneca for $12 million following a review of strategic alternatives by the clinical-stage biopharmaceutical company.